| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
QT Vascular Ltd (SG: 5I0)
5I0 Technical Analysis
1
| As on N/A 5I0 SHARE Price closed @ N/A and we RECOMMEND N/A for LONG-TERM with Stoploss of N/A & N/A for SHORT-TERM with Stoploss of N/A we also expect STOCK to react on Following IMPORTANT LEVELS. |
5I0SHARE Price
| Open | N/A | Change | Price | % |
| High | N/A | 1 Day | N/A | N/A |
| Low | N/A | 1 Week | N/A | N/A |
| Close | N/A | 1 Month | N/A | N/A |
| Volume | N/A | 1 Year | N/A | N/A |
| 52 Week High N/A | 52 Week Low N/A | ||||
SG Singapore Most Active Stocks
| S51 | 0.12 | 0.00% |
| A50 | 0.06 | 0.00% |
| Y92 | 0.57 | 1.79% |
| G13 | 0.94 | -1.05% |
| S58 | 2.52 | 2.02% |
| Z74 | 2.43 | -0.82% |
| C6L | 7.25 | 3.57% |
| N2IU | 1.61 | -1.83% |
| J91U | 0.32 | 0.00% |
| A7RU | 0.48 | 0.00% |
SG Singapore Top Gainers Stocks
SG Singapore Top Losers Stocks
| 5I0 Daily Charts |
5I0 Intraday Charts |
Whats New @ Bazaartrend |
5I0 Free Analysis |
|
|
5I0 Important Levels Intraday
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE |
5I0 Forecast April 2024
| 4th UP Forecast | |
| 3rd UP Forecast | |
| 2nd UP Forecast | |
| 1st UP Forecast | |
| 1st DOWN Forecast | |
| 2nd DOWN Forecast | |
| 3rd DOWN Forecast | |
| 4th DOWN Forecast |
5I0 Weekly Forecast
| 4th UP Forecast | |
| 3rd UP Forecast | |
| 2nd UP Forecast | |
| 1st UP Forecast | |
| 1st DOWN Forecast | |
| 2nd DOWN Forecast | |
| 3rd DOWN Forecast | |
| 4th DOWN Forecast |
5I0 Forecast2024
| 4th UP Forecast | |
| 3rd UP Forecast | |
| 2nd UP Forecast | |
| 1st UP Forecast | |
| 1st DOWN Forecast | |
| 2nd DOWN Forecast | |
| 3rd DOWN Forecast | |
| 4th DOWN Forecast |
QT Vascular Ltd ( SG Singapore Symbol : 5I0 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
5I0 Business Profile
QT Vascular Ltd., together with its subsidiaries, engages in the design, assembly, and distribution of advanced therapeutic solutions for the minimally invasive treatment of complex vascular diseases. The company provides coronary products, including Chocolate percutaneous transluminal coronary angioplasty (PTCA) balloon catheter to reduce vessel trauma by providing balloon inflation; and Glider PTCA balloon catheter for the treatment of various complex lesions. It also offers Chocolate percutaneous transluminal angioplasty (PTA) balloon catheter for atraumatic dilatation in the treatment of blocked arteries; Chocolate Touch PTA balloon catheter to treat peripheral vascular disease; GliderfleX PTA balloon catheter for treating distal peripheral vessels; and GliderXtreme PTA balloon catheter that targets complex lesions in the distal peripheral vasculature. It has operations in the United States, Europe, and Singapore. The company was incorporated in 2005 and is based in Singapore. Address: 18 Boon Lay Way, Singapore, Singapore, 609966
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service